Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by Ifenprodil: The role of Sigma-1 and IP3 receptors

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Ishima, Tamaki ^a   Hashimoto, Kenji ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; 2 AMINOETHOXYDIPHENYLBORANE; 4 BENZYL ALPHA (4 HYDROXYPHENYL) BETA METHYL 1 PIPERIDINEPROPANOL; ALPHA 1 ADRENERGIC RECEPTOR; IFENPRODIL; IFENPRODIL TARTRATE; INOSITOL TRISPHOSPHATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NERVE GROWTH FACTOR; OPIATE ANTAGONIST; PRAZOSIN; SIGMA 1 OPIATE RECEPTOR; SM 21; TROPANYL 2 (4 CHLOROPHENOXY)BUTANOATE MALEATE; UNCLASSIFIED DRUG; XESTOSPONGIN C; 1,2 BIS(2 AMINOPHENOXY)ETHANE N,N,N',N' TETRAACETIC ACID ACETOXYMETHYL ESTER; 1,2-BIS(2-AMINOPHENOXY)ETHANE N,N,N',N'-TETRAACETIC ACID ACETOXYMETHYL ESTER; CALCIUM; CHELATING AGENT; DRUG DERIVATIVE; EGTAZIC ACID; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PIPERIDINE DERIVATIVE; SIGMA OPIATE RECEPTOR; SIGMA-1 RECEPTOR; VASODILATOR AGENT;

ANALYSIS OF VARIANCE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENTIATION; GROWTH INHIBITION; IMMUNOCYTOCHEMISTRY; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; ANIMAL; CELL STRAIN; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; NERVE CELL; NEURITE; RAT;

ANIMALS; CALCIUM; CHELATING AGENTS; EGTAZIC ACID; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; NERVE GROWTH FACTOR; NEURITES; NEURONS; PC12 CELLS; PIPERIDINES; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SIGMA; VASODILATOR AGENTS;

EID: 84861369885     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037989     Document Type: Article

References (37)

1. Hayashi T, Su TP, (2007) Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival. Cell 131: 596-610.
2. Hayashi T, Su TP, (2008) An update on the development of drugs for neuropsychiatric disorders: focusing on the sigma-1 receptor ligand. Expert Opin Ther Targets 12: 45-58.
3. Hayashi T, Tsai SY, Mori T, Fujimoto M, Su TP, (2011) Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders. Expert Opin Ther Targets 15: 557-577.
4. Maurice T, Su TP, (2009) The pharmacology of sigma-1 receptors. Pharmacol Ther 124: 195-206.
5. Maurice T, Urani A, Phan VL, Romieu P, (2001) The interaction between neuroactive steroids and the sigma-1 receptor function: behavioral consequences and therapeutic opportunities. Brain Res Rev 37: 116-132.
6. Hashimoto K, (2009) Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship. Cent Nerv Syst Agents Med Chem 9: 197-204.
7. Hashimoto K, (2009) Can sigma-1 receptor agonist fluvoxamine prevent schizophrenia? CNS & Neurological Disorders- Drug Targets 8: 470-474.
8. Hashimoto K, Fujita Y, Iyo M, (2007) Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors. Neuropsychopharmacology 32: 514-522.
9. Hashimoto K, Ishiwata K, (2006) Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals. Curr Pharm Des 12: 3857-3876.
10. Hindmarch I, Hashimoto K, (2010) Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered. Hum Psychopharmacol 25: 193-200.
11. Ishikawa M, Hashimoto K, (2010) The role of sigma-1 receptors in the pathophysiology of neuropsychiatric diseases. J Receptor Ligand Channel Res 3: 25-36.
12. Monnet FP, Maurice T, (2006) The sigma-1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects. J Pharmacol Sci 100: 93-118.
13. Niitsu T, Iyo M, Hashimoto K, (2012) Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases. Curr Pham Des 18: 875-883.
14. Yoshida T, Iyo M, Hashimoto K, (2012) Recent advances in the potential therapeutic drugs for cognitive deficits in schizophrenia. Curr Psychiatry Rev in press.
15. Hashimoto K, Furuse T, (2012) Sigma-1 receptor agonist fluvoxamine for delirium in elderly adults. Int J Geriatr Psychiatry in press.
16. Takebayashi M, Hayashi T, Su TP, (2002) Nerve growth factor-induced neurite sprouting in PC12 cells involves sigma-1 receptors: implications for antidepressants. J Pharmacol Exp Ther 303: 1227-1237.
17. Nishimura T, Ishima T, Iyo M, Hashimoto K, (2008) Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways. PLoS ONE 3: e2558.
18. Ishima T, Nishimura T, Iyo M, Hashimoto K, (2008) Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: role of sigma-1 receptors and IP3 receptors. Prog Neuropsychopharmacol Biol Psychiatry 32: 1656-1659.
19. Williams K, (2001) Ifenprodil, a novel NMDA receptor antagonist: site and mechanisms of action. Curr Drug Targets 2: 285-298.
20. Mony L, Kew JNC, Gunthorpe MJ, Paoletti P, (2009) Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential. Bri J Pharmacol 157: 1301-1317.
21. Hashimoto K, London ED, (1993) Further characterization of [3H]ifenprodil binding to sigma receptors in rat brain. Eur J Pharmacol 236: 159-163.
22. Hashimoto K, Mantione CR, Spada MR, Neumyer JL, London ED, (1994) Further characterization of [3H]ifenprodil binding in rat brain. Eur J Pharmacol 266: 67-77.
23. Hashimoto K, London ED, (1995) Interactions of erythro-ifenprodil, threo-ifenprodil, erythro-iodoifenprodil, and eliprodil with subtypes of sigma receptors. Eur J Pharmacol 273: 307-310.
24. Das KP, Freudenrich TM, Mundy WR, (2004) Assessment of PC12 cell differentiation and neurite growth: A comparison of morphological and neurochemical measures. Neurotoxicol Teratol 26: 397-406.
25. Okuyama S, Nakazato A, (1996) NE-100: A novel sigma receptor antagonist. CNS Drug Rev 2: 226-237.
26. Ghelardini C, Galeotti N, Bartolini A, (2000) Pharmacologixcal identification of SM-21, the novel sigma-2 antagonist. Pharmacol Biochem Behav 67: 659-662.
27. Mutel V, Buchy D, Klingelschmidt A, Messer J, Messer J, et al. (1998) In vitro binding properties in rat brain of [3H]Ro 25-6981, a potent and selective antagonist of NMDA receptors containing NR2B subunits. J Neurochem 70: 2147-2155.
28. Gafni J, Munsch JA, Lam TH, Catlin MC, Costa LG, et al. (1997) Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor. Neuron 19: 723-733.
29. Maruyama T, Kanaji T, Nakade S, Kanno T, Mikoshiba K, (1997) 2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of ins (1,4,5)P3-induced Ca2+ release. J Biochem 122: 498-505.
30. Ma HT, Patterson RL, van Rossum DB, Birnbaumer L, Mikoshiba K, et al. (2000) Requirement of the inositol trisphosphate receptor for activation of store-operated Ca2+ channels. Science 287: 1647-1651.
31. Williams EJ, Doherty P, Turner G, Reid RA, Hemperly JJ, et al. (1992) Calcium influx into neurons can solely account for cell contact-dependent neurite outgrowth stimulated by transfected L1. J Cell Biol 119: 883-892.
32. Takeshita M, Banno Y, Nakamura M, Otsuka M, Teramachi H, et al. (2011) The pivotal role of intracellular calcium in oxaliplatin-induced inhibition of neurite outgrowth but not cell death in differentiated PC12 cells. Chem Res Toxicol 24: 1845-1852.
33. Kishimoto A, Kaneko M, Gotoh Y, Hashimoto K, (2012) Ifenprodil for the treatment of flashbacks in female posttraumatic stress disorder patients with a history of childhood sexual abuse. Biol Psychiatry 71: e7-e8.
34. Chambers RA, Bremner JD, Moghaddam B, Southwick SM, Charney DS, et al. (1999) Glutamate and post-traumatic stress disorder: toward a psychobiology of dissociation. Semin Clin Neuropsychiatry 4: 274-281.
35. Cortese BM, Phan KL, (2005) The role of glutamate in anxiety and related disorders. CNS Spectr 10: 820-830.
36. Itoh K, Ishima T, Kehler J, Hashimoto K, (2011) Potentiation of NGF-induced neurite outgrowth in PC12 cells by papaverine: Role played by PLC-γ, IP3 receptors. Brain Res 1377: 32-40.
37. Minase T, Ishima T, Itoh K, Hashimoto K, (2010) Potentiation of nerve growth factor-induced neurite outgrowth by the ROCK inhibitor Y-27632: A possible role of IP3 receptors. Eur J Pharmacol 648: 67-73.